SEC 13F Intelligence

Skandinaviska Enskilda Banken AB (Publ) / PFE

Skandinaviska Enskilda Banken AB (Publ)’s Pfizer Inc Position

Does Skandinaviska Enskilda Banken AB (Publ) own Pfizer Inc (PFE)? Not currently — the last reported position was 1.24M shares worth $31M in Q4 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$31M
Q4 2025
Shares
1.24M
% of Portfolio
+0.12%
Quarters Held
29
position exited

Position History PFE

Reported value by quarter
Q4 ’18: $351MQ4 ’18Q1 ’19: $107MQ2 ’19: $73MQ3 ’19: $56MQ4 ’19: $93MQ4 ’19Q1 ’20: $88MQ2 ’20: $89MQ3 ’20: $104MQ4 ’20: $121MQ4 ’20Q1 ’21: $100MQ2 ’21: $107MQ3 ’21: $155MQ4 ’21: $275MQ4 ’21Q1 ’22: $280MQ2 ’22: $277MQ3 ’22: $198MQ4 ’22: $213,937Q4 ’22Q1 ’23: $144,014Q2 ’23: $59,836Q3 ’23: $55,618Q4 ’23: $41MQ4 ’23Q1 ’24: $37MQ2 ’24: $32MQ3 ’24: $33MQ4 ’24: $30MQ4 ’24Q1 ’25: $30MQ2 ’25: $29MQ3 ’25: $28MQ4 ’25: $31MQ4 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q4 20251.24M$31M+0.12%
Q3 20251.11M$28M+0.11%
Q2 20251.19M$29M+0.13%
Q1 20251.17M$30M+0.15%
Q4 20241.14M$30M+0.14%
Q3 20241.15M$33M+0.15%
Q2 20241.14M$32M+0.15%
Q1 20241.33M$37M+0.18%
Q4 20231.44M$41M+0.24%
Q3 20231.68M$55,618+0.37%
Q2 20231.63M$59,836+0.39%
Q1 20233.53M$144,014+1.01%
Q4 20224.18M$213,937+1.61%
Q3 20224.53M$198M+1.53%
Q2 20225.28M$277M+2.04%
Q1 20225.39M$280M+1.64%
Q4 20214.71M$275M+1.42%
Q3 20213.60M$155M+0.85%
Q2 20212.73M$107M+0.66%
Q1 20212.76M$100M+0.66%
Q4 20203.29M$121M+0.83%
Q3 20202.83M$104M+0.76%
Q2 20202.71M$89M+0.72%
Q1 20202.70M$88M+0.94%
Q4 20192.38M$93M+0.73%
Q3 20191.57M$56M+0.48%
Q2 20191.69M$73M+0.63%
Q1 20192.52M$107M+0.98%
Q4 20188.04M$351M+3.14%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Skandinaviska Enskilda Banken AB (Publ)’s full portfolio or all institutional holders of PFE.